Creative Biolabs-Immuno-oncology

Anti-CCL2 (clone MC5L9Q) SynExpress C-Cy5-β-B Modified CD8+ T cells (CAT#: ITS-1224-CR275)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CCL2 (clone MC5L9Q). We employs the AAV (CMV-Cy5-β-catenin-BamHI) vector components and the SynExpress system of the Single base pair Knockout/Positive feedback for a robust and sustained response against cancers.
Host
Human
Target
CCL2
Clone
MC5L9Q
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
Cy5
Promoter
CMV
Effector Gene
β-catenin
Insertion Sites
BamHI
Gene Modification
Knockout
Modification Domain
Single base pair
Carrier Type
AAV
Transformation Accuracy
0.87
Cell Culture
Suspension Culture
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.